Long‐term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID‐19: A 2.5‐year follow‐up study
- 26 July 2023
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 111 (4) , 636-643
Abstract
Objectives: This study investigated whether patients with sickle cell disease (SCD) had elevated risk of worse long‐term clinical outcomes and healthcare utilization 2.5 years post‐SARS‐CoV‐2 infection.Methods: This study consisted of 178 patients with SCD who tested positive for COVID‐19 between February 1, 2020 and January 30, 2022 in a major academic health system in New York City. The control cohort consisted of two‐to‐one matches of 356 SCD patients without a COVID‐19 positive test. The last follow‐up was July 18, 2022. The primary outcome was mortality. Secondary outcomes were annualized emergency department visits due to pain, pain hospital admission, length of stay due to pain, acute chest syndrome, episodic transfusion, and episodic exchange transfusion.Results: There was no significant difference in mortality between SCD patients with and without COVID‐19 (p > .05). There were no significant differences in secondary outcomes between pre‐ and postpandemic (p > .05). There were also no significant differences in these outcomes between SCD patients with and without COVID‐19 (p > .05). SCD care utilization was not significantly associated with COVID‐19 hospitalization status (p > .05).Conclusions: SCD patients with SARS‐CoV‐2 infection incurred no additional risk of worse long‐term outcomes compared to matched controls of SCD patients not infected by SARS‐CoV‐2.Keywords
This publication has 27 references indexed in Scilit:
- Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from MexicoAnnals of Epidemiology, 2020
- Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020Emerging Infectious Diseases, 2020
- Anemia is associated with severe illness in COVID‐19: A retrospective cohort studyJournal of Medical Virology, 2020
- Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular ScienceCardiovascular Research, 2020
- A Saudi family with sickle cell disease presented with acute crises and COVID‐19 infectionPediatric Blood & Cancer, 2020
- Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USAHemoglobin, 2020
- CE: Understanding the Complications of Sickle Cell DiseaseAJN, American Journal of Nursing, 2019
- Epidemiology: A moving targetNature, 2014
- Population Estimates of Sickle Cell Disease in the U.S.American Journal of Preventive Medicine, 2010
- TheRPackagegeepackfor Generalized Estimating EquationsJournal of Statistical Software, 2006